|
|
|
|
|
|
|
Opiant Pharmaceuticals Inc. (OPNT)
|
|
17.21 0.14 (0.82%)
|
10-19 16:00
|
|
Open:
|
16.95
|
Pre. Close:
|
17.07
|
|
High:
|
17.431
|
Low:
|
16.9255
|
|
Volume:
|
11,317
|
Market Cap:
|
65M
|
|
|
|
Stock Price Prediction (Update at 5:00pm est.)
|
|
If
tomorrow:
|
Open
lower
|
Open
higher
|
|
High:
|
17.453 - 17.523
|
17.523 - 17.59
|
|
Low:
|
16.756 - 16.833
|
16.833 - 16.907
|
|
Close:
|
17.086 - 17.207
|
17.207 - 17.324
|
|
|
|
Technical analysis (as of: 2018-10-19 4:37:58 PM)
|
|
Overall:
|
 
|
|
Stoxline posted a BUY today, upgraded from lower rating. This stock seems to be ready for a new bullish move. If you bought, continue to hold stock until SELL signal. You are relatively safe to buy now, a new upward move is expected.
|
|
Target:
|
Six months: 23.89 One year: 27.25
|
|
Support:
|
Support1: 15.81 Support2: 13.15
|
|
Resistance:
|
Resistance1:
20.46 Resistance2: 23.33
|
|
Pivot:
|
17.33 
|
|
Moving Averages:
|
MA(5): 17.03 MA(20): 17.57
MA(100): 16.88 MA(250): 20.99
|
|
MACD:
|
MACD(12,26):
-0.68 Signal(12,26,9): -0.64
|
|
%K %D:
|
%K(14,3): 30.07 %D(3): 28.80
|
|
RSI:
|
RSI(14): 42.46
|
|
52-Week:
|
High: 48
Low: 12.75 Change(%): -44.1
|
|
Average Vol(K):
|
3-Month: 6601
10-Days 3682
|
|
|
|
|
|
★
Strong Sell
★★
Sell ★★★
Neutral
★★★★
Buy
★★★★★
Strong Buy
|
|
|
Price, moving averages and
Bollinger Bands
|
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.OPNT has closed above bottom band by 44.7%. Bollinger Bands are 53.8% narrower than normal. The narrow width of the bands suggests low volatility as compared to OPNT's normal range. The bands have been in this narrow range for 4 bars. This is a sign that the market may be about to initiate a new trend.
|
|
|
Headline News
|
|
2018-10-18T09:38:37-04:00
Opiant Pharmaceuticals' OPNT005 receives grant for development of a heroin vaccine
|
|
|
Financial Analysis
|
|
Growth
|
|
|
Growth measures the growth of both a company's revenue
and net income. it tells investors how fast a company is growing.
|
|
Profitability
|
|
|
Profitability measures a company’s ability to
generate earnings as compared to its expenses
and other relevant costs.
|
|
Solvency
|
|
|
Solvency measures a company's ability to meet its long-term debts.
Acceptable solvency ratios will vary from industry to industry.
|
|
Efficiency
|
|
|
Efficiency measures the strength of a company's return on invested capital.
It can identify business that are better managed or not.
|
|
Click here to get more fundamental analysis.
|
|
